Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest lidocaine Stories

2008-09-29 09:00:15

Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced results from its Phase II study of vaginally-administered lidocaine, which the Company is investigating for the prevention and treatment of dysmenorrhea. No treatment currently exists to prevent dysmenorrhea. Seventy women with a history of moderate-to-severe dysmenorrhea participated in this first documented attempt to show prevention of uterine cramping and pain. This double-blind, placebo-controlled clinical trial used a...

2008-09-08 09:00:52

Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that its third party data management consultants have confirmed that the results from the Company's recently completed Phase II clinical trial evaluating vaginal lidocaine for the prevention and treatment of dysmenorrhea (a condition typified by painful menstruation) will be available on or before September 29, 2008. The Company had previously expected top line data to be available at the end of August. Robert S. Mills,...

2008-08-21 09:01:14

LONDON, August 21 /PRNewswire/ -- The medicated pain relief plaster, (Versatis) is now approved by the Scottish Medicines Consortium (SMC) for restricted use within NHS Scotland for patients suffering pain following shingles(1) http://www.scottishmedicines.org.uk/smc/5850.html. This reversal of the previous SMC decision (issued in February 2007) for Versatis (5% lidocaine medicated plaster) is based on significant new clinical and cost-effectiveness comparative data and brings prescribing...

9c049d6b86092b909284a56d9784b50f1
2008-07-23 09:05:00

Over-the-counter anesthetic gel puts the squeeze on mammogram pain The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of Radiology. "We now have something that we know reduces discomfort with screening mammography in women who expect higher discomfort"”lidocaine gel," said the trial's principal investigator, Colleen Lambertz, F.N.P., a...

2008-06-30 09:03:37

CUPERTINO, Calif., June 30 /PRNewswire-FirstCall/ -- DURECT Corporation announced today that the US Food and Drug Administration (FDA) has granted to DURECT orphan drug designation for bupivacaine for relief of persistent pain associated with post-herpetic neuralgia (PHN). Bupivacaine is the active pharmaceutical ingredient in ELADUR(TM), DURECT's investigational transdermal drug patch. If ELADUR is the first bupivacaine product approved for PHN, under the 1983 Orphan Drug Act ELADUR will...

2008-06-26 09:03:12

SAN MATEO, Calif., June 26 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. today announced the publication of five studies in the June 2008 issue of the Journal of Dermatologic Surgery, a peer-reviewed publication of the American Society of Dermatologic Surgery. The five published clinical and preclinical reports were: -- A 52-Month Summary of Results Using Calcium Hydroxylapatite for Facial Soft Tissue Augmentation - THOMAS L. TZIKAS, MD -- An Investigation of Changes in Physical...

2008-05-09 03:00:13

By Hong, Jeong-Yeon Lim, Kyung T Background and Objective: Surgical stress and general anesthesia suppress immune function. Preemptive epidural analgesia can affect the perioperative immune responses, and influence cancer management. Methods: Forty women undergoing elective laparoscopic radical hysterectomy for cervical cancer were allocated to this prospective, randomized, double-blind trial. Before inducing anesthesia, 2 mg morphine dissolved in 15 mL of 1 % lidocaine (preemptive group)...

2006-12-19 09:01:26

Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) announced today the submission of a Citizen Petition with the U.S. Food and Drug Administration requesting that the FDA apply existing bioequivalence regulations to any Abbreviated New Drug Application (ANDA) seeking regulatory approval of a generic drug product that references Endo's Lidoderm(R) (lidocaine topical patch 5%). As disclosed on October 17, 2006, Endo became aware that, in response to an independent inquiry, the FDA's Office of...

2005-12-05 12:30:58

NEW YORK (Reuters Health) - Men undergoing a prostate biopsy may experience less discomfort if they're given a suppository containing the local anesthetic lidocaine a couple of hours before the procedure. While a biopsy when prostate cancer is suspected can be life saving -- or help avoid unnecessary surgery if it proves negative -- the procedure can be uncomfortable or even painful. It involves insertion of an ultrasound probe into the rectum so the prostate can be visualized, and...

2005-10-21 19:29:52

Lidocaine and similar local anesthetics are effective for treating pain that emanates from damaged nerves, according to a systematic review of current evidence. Neuropathic pain, which can occur with chronic diseases or conditions, is frequently unresponsive to treatment and worsens over time. "Intravenous lidocaine and oral derivatives relieve pain from damage to the nervous system," found authors Ivo W. Tremont-Lukats, M.D., of the M.D. Anderson Cancer Center in Houston, and colleagues....